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n the article by Fuster V, Rydén LE, Cannom DS, et al., “ACC/AHA/ESC 2006 Guidelines for the Management of
atients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force
n Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to
evise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation),” which appeared in the August 15,
006, issue of the journal (J Am Coll Cardiol 2006;48:e149–e246), the following corrections are needed:
Table 23. This table should be retitled to “Pharmacological Treatment Before Cardioversion in Patients With Persistent
F: Effects of Various Antiarrhythimic Drugs on Immediate Recurrence, Outcome of Transthoracic Direct-Current Shock,
r Both”
Quinidine should be deleted from the table (Enhance Conversion by DC Shock and Prevent IRAF* column).
The authors prefer that the third column be transposed to the fifth column.
The Recommendation Class for the treatments with known efficacy (row 1, column 4) is IIa rather than I.
doi:10.1016/j.jacc.2007.05.007
n the article by Fuster V, Rydén LE, Cannom DS, et al., “ACC/AHA/ESC 2006 Guidelines for the Management of
atients With Atrial Fibrillation—Executive Summary: A Report of the American College of Cardiology/American Heart
ssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines
Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation),” which
ppeared in the August 15, 2006, issue of the journal (J Am Coll Cardiol 2006;48:854–906), the following corrections are
eeded:
Table 18. This table should be retitled to “Pharmacological Treatment Before Cardioversion in Patients With Persistent
F: Effects of Various Antiarrhythimic Drugs on Immediate Recurrence, Outcome of Transthoracic Direct-Current Shock,
r Both”
Quinidine should be deleted from the table (Enhance Conversion by DC Shock and Prevent IRAF* column).
The authors prefer that the third column be transposed to the fifth column.
The Recommendation Class for the treatments with known efficacy (row 1, column 4) is IIa rather than I.
doi:10.1016/j.jacc.2007.05.008
